Skip to content

Cytek Biosciences, Inc. CTKB Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$44.1M+6.5%
Gross profit$21.3M+5.4%
Operating income-$18.5M-23.3%
Net income-$18.9M-65.5%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$31.8M-66.6%
Total debt$16.8M+40.9%
Total equity$327.6M-13.7%
Total assets$449.1M-6.9%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+155%
Free cash flow-$4.9M-403%

Valuation

See full
Market cap$577.27M+54.5%
Enterprise value$562.23M+93.7%
P/S2.8×+0.9×

Profitability

See full
Gross margin51.7%-3.2pp
Operating margin-21.5%
Net margin-36.2%
FCF margin-6.2%-15.1pp

Returns & leverage

See full
Return on equity-20.9%
Debt / equity0.1×0.0×
Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s software and technology licenses, net?
Cytek Biosciences, Inc. (CTKB) reported software and technology licenses, net of $6.31M in Q1 2026.
How has Cytek Biosciences, Inc.'s software and technology licenses, net changed year-over-year?
Cytek Biosciences, Inc.'s software and technology licenses, net increased by 37.9% year-over-year, from $4.57M to $6.31M.
What is the long-term trend for Cytek Biosciences, Inc.'s software and technology licenses, net?
Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s software and technology licenses, net has grown at a 43.8% compound annual growth rate (CAGR), from $1.09M to $6.7M.